He pointed to a study in which one-fifth of patients with newly diagnosed follicular lymphoma who went with a watch-and-wait approach had at least one GELF criteria, while more than one-third who ...

Sporadic papillary renal-cell carcinoma represents a heterogeneous group of tumors characterized by diverse histologic, genetic, and molecular features. 3,23 Single-group, phase 2 studies have ...

Northwestern Medicine scientists have discovered how cells responsible for hair growth perceive physical forces in their environment and utilize that information to regulate their growth ...

Patients with relapsed/refractory (R/R) follicular lymphoma reported consistent or increased response rates, survival benefits, and health-related quality of life (HRQOL) when taking epcoritamab ...

Proceeds to fund Phase 1/2 trial of EO2463 OncoMimics™, as a monotherapy or in combination, to treat multiple forms of indolent non-Hodgkin lymphoma (iNHL) $9 million from new investor The Institute ...

It turned out that both tumors were malignant. I had two different kinds of thyroid cancer, follicular and papillary, and both were completely removed during the surgery.

Long-term results of a phase 3 trial show that early rituximab monotherapy significantly delays the need for new treatment in patients with asymptomatic, low tumour burden follicular lymphoma.

Soon-Shiong further stated: “The Agency must explain the confounding inconsistency of approving ANKTIVA+BCG for patients with Papillary with CIS disease, while refusing to file the sBLA for ...

The TAR-200 system offering sustained intravesical gemcitabine release shows favorable response and tolerability in both the CIS and papillary-only subgroups with BCG-unresponsive high-risk NMIBC.

Graphical Abstract. Relative survival with and without radioiodine therapy (RAI) in intermediate risk papillary thyroid cancer (PTC) and low risk, minimally invasive follicular thyroid cancer (FTC).

A supplemental Biologics License Application has been submitted to the FDA for Anktiva plus BCG in papillary NMIBC.

Living with follicular lymphoma, I challenge common misconceptions about cancer, highlighting the unique and varied experiences of patients with cancer.